메뉴 건너뛰기




Volumn 16, Issue 4, 2002, Pages 531-536

Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma

Author keywords

CD16 56; CD19; CD4; CD8; Chemotherapy; HIV viral load; Lymphoma

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; BLEOMYCIN; CD16 ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISOLONE; VINBLASTINE; VINCRISTINE; VIRUS RNA;

EID: 0037040371     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200203080-00003     Document Type: Article
Times cited : (87)

References (20)
  • 1
    • 0033969247 scopus 로고    scopus 로고
    • T-cell immunodeficiency following cytotoxic antineoplastic therapy: A review
    • (2000) Stem Cells , vol.18 , pp. 10-18
    • Mackall, C.1
  • 4
    • 0029099349 scopus 로고
    • Infectious and immunosuppressive complications of purine analog therapy
    • (1995) J Clin Oncol , vol.13 , pp. 2431-2448
    • Cheson, B.1
  • 10
    • 0032971372 scopus 로고    scopus 로고
    • Population biology of HIV-1 infection: Viral and CD4+ T cell demographics and dynamics in lymphatic tissues
    • (1999) Annu Rev Immunol , vol.17 , pp. 625-656
    • Haase, A.1
  • 15
    • 10344236461 scopus 로고    scopus 로고
    • Pilot trial of infusional cyclophosphamide, doxorubicin and etoposide plus didanosine and filgrastim in patients with HIV associated non-Hodgkin's lymphoma
    • (1996) J Clin Oncol , vol.14 , pp. 3026-3035
    • Sparano, J.A.1    Wiernik, P.H.2    Hu, X.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.